NEW YORK, August 9, 2017 /PRNewswire/ --
According to a researchreport published by New Frontier Data, medical cannabis sales are forecast to grow to $5.3 billion in 2017, or accounting for 67% of total cannabis sales. By 2025, medical sales in currently legal states are forecast to
"Cannabis stocks significantly outperformed major indexes in 2016, fueled by speculative investment based on anticipated expansion of new legal markets. In the run up to the election, stocks increased by 207.8% and continued to rise, even with an uncertain future under the new administration. While recent comments by the Trump administration did have an initial dampening effect on the market, we have seen continued growth relative to Q4 2016 whereby cannabis stocks are still outperforming other sectors," said Giadha Aguirre De Carcer, CEO of New Frontier Data.
Global Payout, Inc. (OTC: GOHE) announced on July 27th that Marijuana Company of America, Inc. (OTC: MCOA) has completed an investment of $250,000 into MoneyTrac Technology, Inc. ("MTT"), a subsidiary of Global Payout, Inc., in exchange for a 15% ownership interest.
MCOA made this investment to help establish and market MTT as an alternative banking solution for the cannabis industry. MoneyTrac's software has the ability to integrate and streamline electronic payment processing, such as E-Wallet and mobile applications, as well as manage and process prepaid cards, debit cards, and credit card payments.
As part of the terms of the investment, Donald Steinberg, CEO and President of MCOA, was appointed to the board of MTT this year where he is lending the invaluable experience he has acquired throughout his career in building alternative financial solution companies to the MTT executive management team.
"We are excited to help guide MTT through its developmental stages and are optimistic about the potential of MCOA's investment into this new project. This is another example of MCOA's strong strategic partnerships with emerging companies in our industry," Donald Steinberg said.
CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. Earlier in June the company announced that, it held its pre-IND meeting with the U.S. Food and Drug Administration (FDA) on June 15, 2017, to review its drug development plan for CVSI-007, the Company's patent-pending product for smokeless tobacco addiction therapy consisting of nicotine-polacrilex chewing gum in combination with synthetic cannabidiol (CBD). CV Sciences President and CEO Michael J. Mona, Jr. commented, "Our pre-IND meeting with the FDA was very constructive and provided the Company with a favorable development roadmap for this important combination drug candidate. We have immediately commenced preparation of our Investigational New Drug application (IND) to initiate human trials. Our New Drug Application will be under the 505(b)2 pathway using nicotine-polacrilex gum, an FDA-approved nicotine replacement therapy, as our referenced listed drug."
MassRoots Inc. (OTCQB: MSRT) on August 3rd announced that the point-of-sale and compliance software platform it is acquiring and is expected to fully close on August 5, 2017, previously known as Odava, has been re-branded as MassRoots Retail. MassRoots is now prioritizing resources towards its software solutions for licensed dispensaries and connecting its community of over 1,000,000 of the world's top cannabis enthusiasts with the best products and strains in regulated markets. "We believe Facebook is the undisputed leader in social networking and rather than trying to compete, we are focusing our efforts on better connecting our users with the best licensed dispensaries and products. Soon, users will also be able to login to MassRoots with their Facebook accounts," stated MassRoots CEO Isaac Dietrich.
mCig, Inc. (OTCQB: MCIG) a diversified company servicing the legal cannabis markets with innovative products, technologies, and services. Earlier in July mCig provided an update, revealing that the company looks to make an acquisition of existing cultivation, production and distribution licenses in California, Nevada, and other recreational states. In addition, the company has interest in acquiring proprietary cannabis oil extraction technologies and established leading brands that can help accelerate growth and expand the company's reach. The acquisition strategy is intended to strengthen the company's intellectual property and national presence, while further building the mCig portfolio and driving financial and shareholder value.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: firstname.lastname@example.org +1-877-601-1879
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All